USE OF (R)-3-[1-(2,6-DICHLORO-3-FLUROR-PHENYL)-ETHOXYL]-5-(1-PIPERIDIN-4-YL-1H-PYRAZOL-4-YL)-PYRIDIN-2-YLAMINE FOR TREATMENT OF CANCER

摘要

The present invention relates to the use of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1- piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, a novel c-Met/HGFR inhibitor, for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer.